Seung Yong Seong
Inventor
Stats
- 2 US patents issued
- 13 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 13 US Applications Filed
- 2 Total Citation Count
- Nov 18, 2024 Most Recent Filing
- Mar 5, 2014 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
SHAPERON INC. | 2
2 | 2014
2017 |
Inventor Addresses
Address | Duration |
---|---|
Seoul, KR | Oct 15, 15 - Mar 27, 25 |
Songpa-gu, Seoul, KR | Apr 25, 24 - Jul 11, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 8 |
A61Q: | USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0099,487 | 2025 | COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS, COMPRISING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | 0 |
2025/0084,170 | 2025 | BISPECIFIC HUMANIZED SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47, AND USE THEREOF | 0 |
2025/0000,877 | 2025 | COMPOSITION CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL INFECTIOUS DISEASES | 0 |
2024/0391,948 | 2024 | NOVEL COMPOUND THAT INHIBITS TNF-ALPHA GENERATION AND INFLAMMASOME ACTIVITY AND PREPARATION METHOD THEREFOR | 0 |
2024/0228,613 | 2024 | SINGLE DOMAIN ANTIBODY AGAINST CD47 AND USE THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.